Veru Inc.
VERU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000863894
In the last 90 days, Veru Inc. insiders filed 1 open-market purchase and 0 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $9.45M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Veru Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 1 filing
- 1 insider, $4.84K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$4.84K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Veru Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Barnette K Gary | Chief Scientific Officer | 2,300 | Aug 17, 2026 | 3 |
| Steiner Mitchell Shuster | President and CEO | 6,942,709 | May 6, 2026 | 2 |
| Rankowitz Michael L | Director | 250,000 | May 6, 2026 | 3 |
| Lu Lucy | Director | 9,800 | May 6, 2026 | 3 |
| Greco Michele | Chief Admin Officer and CFO | – | May 6, 2026 | 2 |
| Fisch Harry | Chief Corporate Officer | 774,736 | May 6, 2026 | 2 |
| Hyun Grace | Director | – | May 6, 2026 | 3 |
| Katzovitz Loren Mark | Director | – | May 6, 2026 | 2 |
| Eisenberger Mario | Director | 0 | Oct 2, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 (view filing)4:26 PM ET | Aug 13 | 4 days | Barnette K GaryChief Scientific Officer | PPurchase | +1.80K | $2.69 | +$4.84K | +360.0%2.30K after | |
| Feb 20, 2025 (view filing) | Feb 18-19 | 2 days | Rankowitz Michael LDirector | PPurchase | +150.0K | $0.5609 | +$84.1K | +150.0%250.0K after | 2 lots |
| May 28, 2024 (view filing) | May 24 | 4 days | Fisch HarryChief Corporate Officer | PPurchase | +4.00K | $1.25 | +$5.00K | +0.5%774.7K after | |
| May 24, 2024 (view filing) | May 24 | Same day | Barnette K GaryChief Scientific Officer | PPurchase | +5.00K | $1.34 | +$6.70K | New position5.00K after | |
| May 24, 2024 (view filing) | May 22-24 | 2 days | Steiner Mitchell ShusterPresident and CEO | SSale | −70.2K | $1.25 | −$87.4K | −1.0%6.94M after | 3 lots |
| May 17, 2024 (view filing) | May 15 | 2 days | Fisch HarryChief Corporate Officer | PPurchase | +6.71K | $1.49 | +$10.0K | +0.9%770.7K after | |
| May 17, 2024 (view filing) | May 15-17 | 2 days | Steiner Mitchell ShusterPresident and CEO | SSale | −171.9K | $1.44 | −$247.4K | −2.4%7.01M after | 3 lots |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Eisenberger MarioDirector | SSale | −100.0K | $20.04 | −$2.00M | −100.0%0 after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Lu LucyDirector | PPurchase | +4.80K | $6.78 | +$32.5K | +96.0%9.80K after |